KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ACM Research (ACMR) Depreciation and Depletion (2016 - 2022)

Historic Depreciation and Depletion for ACM Research (ACMR) over the last 7 years, with Q1 2022 value amounting to $1.1 million.

  • ACM Research's Depreciation and Depletion rose 14669.7% to $1.1 million in Q1 2022 from the same period last year, while for Mar 2022 it was $2.7 million, marking a year-over-year increase of 15398.15%. This contributed to the annual value of $6.9 million for FY2023, which is 4283.94% up from last year.
  • ACM Research's Depreciation and Depletion amounted to $1.1 million in Q1 2022, which was up 14669.7% from $692000.0 recorded in Q4 2021.
  • In the past 5 years, ACM Research's Depreciation and Depletion registered a high of $1.1 million during Q1 2022, and its lowest value of $84000.0 during Q3 2018.
  • Its 5-year average for Depreciation and Depletion is $298294.1, with a median of $185000.0 in 2019.
  • As far as peak fluctuations go, ACM Research's Depreciation and Depletion surged by 571.43% in 2020, and later surged by 16926.07% in 2021.
  • Over the past 5 years, ACM Research's Depreciation and Depletion (Quarter) stood at $93000.0 in 2018, then soared by 98.92% to $185000.0 in 2019, then soared by 38.92% to $257000.0 in 2020, then surged by 169.26% to $692000.0 in 2021, then skyrocketed by 56.5% to $1.1 million in 2022.
  • Its Depreciation and Depletion stands at $1.1 million for Q1 2022, versus $692000.0 for Q4 2021 and $501000.0 for Q3 2021.